Evaluating Patient Satisfaction and Quality of Life When Switching From Risperidone to Paliperidone ER (Extended Release) in Stable But Symptomatic Outpatients With Schizophrenia
This study has been completed.
Sponsor:
Janssen-Cilag Farmaceutica Ltda.
Information provided by:
Janssen-Cilag Farmaceutica Ltda.
ClinicalTrials.gov Identifier:
NCT01010776
First received: November 5, 2009
Last updated: February 18, 2010
Last verified: February 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2009 |
| Estimated Primary Completion Date: | No date given |